Short-chain fatty acids in patients with schizophrenia and ultra-high risk population

HIGHLIGHTS

• who: Huiqing Peng from the Elysian Clinic, Brazil Xiangya Hospital of Central South University, Changsha, Hunan, China, Hunan Key Laboratory of have published the Article: Short-chain fatty acids in patients with schizophrenia and ultra-high risk population, in the Journal: (JOURNAL)
• what: The study shows that both SCZ patients and UHR individuals during the prodromal phase who later converted to SCZ had reduced valeric acid levels. In the current study, the level of caproic acid in the UHR population and in both the UHR group and the baseline of UHR individuals who developed into . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.